FDA announces recall of multiple lots of Smiths Medical insulin syringes

The FDA has announced that Smiths Medical is recalling some of its insulin syringes due to inaccurate graduation markings on the syringe barrels. These markings could lead to the administration of an incorrect insulin dose, potentially leading to hyperglycemia or hypoglycemia.

This is a Class I recall, which means the issue could lead to serious injury or death.

In total, Smiths Medical is recalling 13 lots of its Jelco® Hypodermic Needle-Pro® Fixed Needle Insulin Syringe. Customers have been asked to quarantine and return all affected products.

“Markings skewed approximately 20 degrees upward have been identified,” according to the FDA.

More information on this recall is available here.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."